Surgery of gastroesophageal reflux disease: A competitive or complementary procedure?

Digestive Diseases

Volumn 22, Issue 2, 2004, Pages 161-170

  Lundell, Lars ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antireflux surgery; Gastroesophageal reflux disease; Laproscopic antireflux surgery; Medical therapy; Postfundoplication complaints; Recurrent reflux

Indexed keywords

ACID; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ABDOMINAL SURGERY; BARRETT ESOPHAGUS; CANCER INCIDENCE; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE CONTROL; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG RESPONSE; DRUG SAFETY; DRUG SCREENING; DUODENUM; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; HUMAN; INHIBITION KINETICS; LOWER ESOPHAGUS SPHINCTER; MORBIDITY; MORTALITY; PATHOLOGICAL ANATOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY TRACT DISEASE; REVIEW; STOMACH ACID; SURGICAL PATIENT; SURGICAL TECHNIQUE; SURVIVAL; SYMPTOM; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

ANTI-ULCER AGENTS; COMBINED MODALITY THERAPY; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HUMANS; LAPAROSCOPY; RECURRENCE;

EID: 4644244047     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080315     Document Type: Review

References (118)

1. Shaheen N, Provenzale D: The epidemiology of gastroesophageal reflux disease. Am J Med Sci 2003;326:264-273.
2. el-Seraq HB, Sonnenberg A: Opposing trends of peptic ulcer and reflux disease. Gut 1998;43:327-333.
3. Voutilainen M, Sipponen P, Mecklin JP, Juhola M, Farkkila M: Gastroesophageal reflux disease: Prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 2000;61:6-13.
4. Hansson LE, Sparen P, Nyren O: Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer 1993;54:402-407.
5. Parkin DM, Whelan SL, Ferby J, et al: Cancer Incidence in Five Continents. IARC Scientific publ No 143. Lyon, International Agency on Cancer, 1997, vol VII, pp 66-68.
6. Lagergren J, Bergström R, Lindgren A, Nyren O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-831.
7. Ye W, Chow WH, Lagergren J, Yin L, Nyren O: Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux disease and after anti reflux surgery. Gastroenterology 2001;121:1286-1293.
8. Lagergren J, Bergström R, Nyren O: Body mass as a risk factor for esophageal and gastric cardia adenocarcinoma. Ann Intern Med 1999;130:883-890.
9. Lundell L, Dent J: Gastroesophageal reflux disease; in Olbe L (ed): Proton Pump Inhibitors. Berlin, Birkhäuser, 1999, pp 223-238.
10. Ortiz A, Martínez de Haro LF, Parrilla P, Molina J, Bermejo J, Munitiz V: 24-h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's esophagus undergoing treatment with proton pump inhibitors. Br J Surg 1999;86:1472-1474.
11. Katzka DA, Castell DO: Successful elimination of reflux symptoms does not ensure adequate control of acid reflux in Barrett's esophagus. Am J Gastroenterol 1994;89:989-991.
12. Kuo B, Castell DO: Optimal dosing of omeprazole 40 mg daily: Effects on gastric and esophageal pH and serum gastrin in healthy controls. Am J Gastroenterol 1996;91:1532-1538.
13. Ouatu-Lascar R, Triadafilopoulos G: Complete elimination of reflux symptoms does not guarantee normalization of intra-esophageal acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 1998;93:711-716.
14. Leite LP, Johnston BT, Just RJ, et al: Persistent acid secretion during omeprazole therapy: A study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol 1996:91;1527-1541.
15. Stein HJ, Kauer WKH, Feussner H, Siewert JR: Bile reflux benign and malignant Barrett's esophagus: Effect of medical acid suppression and Nissen fundoplication. J Gastrointest Surg 1998;2:333-341.
16. Zhang F, Subbaramaiah K, Altorki N, Dannenberg AJ: Dihydroxy bile acids activate the transcription of cyclooxygenase-2. J Biol Chem 1998;273:2424-2428.
17. Fitzgerald RC, Omary MB, Triadafilopoulos G: Dynamic effects of acid on Barrett's esophagus: An ex vivo proliferation and differentiation model. J Clin Invest 1996;98:2120-2128.
18. Ouatu-Lascar R, Fitzgerald RC, Triadafilopoulos G: Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. Gastroenterology 1999;117:327-335.
19. Shirvani VN, Ouatu-Lascar R, Kaur BS, et al: Cyclo-oxygenase 2 expression in Barrett's esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure. Gastroenterology 2000;118:487-496.
20. 2 receptor antagonists in the treatment of patients with peptic strictures and oesophagitis. Gastroenterology 1994;106:907-915.
21. DeMeester TR, Bonavina L, Lascone C, et al: Chronic respiratory symptoms and occult gastroesophageal reflux: A prospective clinical trial and results of surgical therapy. Ann Surg 1990;211:337-345.
22. Ruth M, Bake B, Sandberg N, et al: Pulmonary function in gastroesophageal reflux disease. Effects of reflux controlled by fundoplication. Dis Esophagus 1994;7:268-275.
23. Ford GA, Oliver PS, Prior JS, et al: Omeprazole in the treatment of asthmatics with nocturnal symptoms and gastro-oesophageal reflux: A placebo-controlled cross-over study. Postgrad Med J 1994;70:350-354.
24. Bammer T, Freeman M, Shahriari A, Hinder RA, DeVault KR, Achem SR: Outcome of laparoscopic antireflux surgery in patients with nonerosive reflux disease. J Gastrointest Surg 2002;6:730-737.
25. Winslow ER, Frisella MM, Nathaniel RN, Soper J, Clouse RE, Klingensmith ME: Patients with upright reflux have less favourable postoperative outcomes after laparoscopic antireflux surgery than those with supine reflux. J Gastrointest Surg 2002;6:819-830.
26. Raftopoulos Y, Papasavas P, Landreneau R, Hayetian F, Sntucci T, Gagné D, Caushaj P, Keenan R: Clinical outcome of laparoscopic antireflux surgery for patients with irritable bowel syndrome. Surg Endosc 2004;18:655-659.
27. Desai KM, Frisella MM, Nathaniel RN, Soper J: Clinical outcomes after laparoscopic antireflux surgery in patients with and without preoperative endoscopic esophagitis. J Gastrointest Surg 2003:7:44-52.
28. Velanovich V: The effect of chronic pain syndromes and psychoemotional disorders on symptomatic and quality-of-life outcomes of antireflux surgery. J Gastrointest Surg 2003;7:53-58.
29. Lundell L, Dalenbäck J, Hattlebakk J, et al: Outcome of open antireflux surgery as assessed in a Nordic multicenter, prospective clinical trial. Nordic GORD Study Group. Eur J Surg 1998;164:751-757.
30. Behar J, Sheahan DG, Biancani P, et al: Medical and surgical management of reflux esophagitis. A 38-month report on a prospective clinical trial. N Engl J Med 1975;293:263-268.
31. Ortiz A, Martinez de Haro LF, Parrilla P, Morales G, Molina J, Bermejo J, Liron R, Aguilar J: Conservative treatment versus antireflux surgery in Barrett's oesophagus: Long-term results of a prospective study. Br J Surg 1996;83:274-278.
32. Parrilla P, Martínez de Haro LF, Ortiz A, Munitiz V, Serrano A, Torres G: Barrett's esophagus without esophageal stricture does not increase the rate of failure of Nissen fundoplication. Ann Surg 2003;237:488-493.
33. Spechler SJ: Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. N Engl J Med 1992;326:786-792.
34. Spechler SJ, Lee E, Ahnen D, et al: Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease. Follow up of a randomized controlled trial. JAMA 2001;285:2331-2338.
35. Hagedorn C, Lonroth H, Rydberg L, Ruth M, Lundell L: Long-term efficacy of total (Nissen-Rossetti) and a posterior partial (Toupet) fundoplication. Results from a randomized clinical trial. J Gastrointest Surg 2002;6:540-545.
36. Booth MI, Jones L, Stratford J, Dehn TCB: Results of laparoscopic Nissen fundoplication at 2-8 years after surgery. Br J Surg 2002;89:476-481.
37. Granderath FA, Kamolz T, Schweiger UM, Pointner R: Quality of life, surgical outcome and patient satisfaction three years after laparoscopic Nissen fundoplication. World J Surg 2002;26:1234-1238.
38. Lundell L, Miettinen P, Myrwold ME, et al: Continued (5-year) follow up of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease. J Am Coll Surg 2001;192:172-179.
39. Lundell L, Miettinen P, Myrwold ME, Wallin L, et al: Medical or surgical treatment for reflux esophagitis: 7-year follow-up of a randomized clinical trial (Abstract) DDW, New Orleans, 2004.
40. Csendes A, Braghetto I, Burdiles P, Puente G, Korn O, Diasz JC, Maluenda F: Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus: Clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation. Surgery 1998;123:545-557.
41. Csendes A, Burdiles P, Korn O, Braghetto I, Huertas C, Maluenda F, Diaz J, Rojas J: Late results of a randomized clinical trial comparing total fundoplication versus calibration of the cardia with posterior gastropexy. Br J Surg 2000;87:289-297.
42. Hofstetter WL, Peters JH, DeMeester TR, et al: Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann Surg 2001;234:532-538.
43. Farrell TM, Smith CD, Metreveli RE, et al: Fundoplication provides effective and durable symptom relief in patients with Barrett's esophagus. Am J Surg 1999;178:18-21.
44. O'Boyle CJ, Watson DI, DeBeaux AC, Jamieson GG: Preoperative prediction of long-term outcome following laparoscopic fundoplication. Aust NZ J Surg 2002;72:471-475.
45. Brand DL, Yenisaker JT, Gelfand M, et al: Regression of columnar esophageal (Barrett's) epithelium after anti reflux surgery. N Engl J Med 1980;302:844-848.
46. Skinner DB, Walther BC, Riddell RH, et al: Barrett's esophagus: Comparison of benign and malignant cases. Ann Surg 1983;198:554-566.
47. Starnes VA, Adkins RB, Ballinger JF, et al: Barrett's esophagus. A surgical entity. Arch Surg 1984;119:563-567.
48. DeMeester TR, Attwood SEA, Smyrk TC, et al: Surgical therapy in Barrett's esophagus. Ann Surg 1990;212:528-542.
49. Williamson WA, Ellis FHE, Gibb SP, Shahian DM, Aretz T: Effect of antireflux operation on Barrett's mucosa. Ann Thorac Surg 1990;49:537-542.
50. McEntee GP Stuart RC, Byrne PS, et al: An evaluation of surgical and medical treatment of Barrett's esophagus. Gullet 1991;1:169-172.
51. McCallum RW, Polepalle S, Dawenport K, et al: Role of antireflux surgery against dysplasia in Barrett's esophagus. Gastroenterology 1991;100:A121.
52. Attwood SEA, Barlow AP, Norris TL, Watson A: Barrett's esophagus: Effect of antireflux surgery on symptom control and development of complications. Br J Surg 1992;79:1050-1053.
53. Sagar PM, Ackroyd R, Hosie KB, Pattersson JE, Stoddard CJ, Kingsnorth AN: Regression and progression of Barrett's esophagus after antireflux surgery. Br J Surg 1995;82:806-810.
54. McDonald ML, Trastek VF, Allen M, Deschamps C, Pairolero PC: Barrett's esophagus: Does an antireflux procedure reduce the need of endoscopic surveillance? J Thorac Cardiovasc Surg 1996;111:1135-1140.
55. DeMeester SR, Campos GMR, DeMeester TR, et al: The impact of antireflux surgery on intestinal metaplasia of the cardia. J Gastrointest Surg 1998;228:547-556.
56. Low DE, Levine DS, Dail DH, Kozarek RA: Histological and anatomic changes in Barrett's esophagus after antireflux surgery. Am J Gastroenterol 1999;94:80-85.
57. Patti MG, Arcentino M, Feo CV, et al: Barrett's esophagus. A surgical disease. J Gastrointest Surg 1999;3:397-404.
58. van der Boom G, Go PMMUH, Hameeteman W, Dallemagne B, et al: Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophageal reflux disease in the Netherlands. Scand J Gastroenterol 1996;31:1-9.
59. Heudebert G, Marks R, Wilcox C, Centor R: Choice of long-term strategy in the management of patients with severe esophagitis: A cost utility analysis. Gastroenterology 1996;112:1078-1086.
60. Viljakka M, Nevalainen J, Isolauri J: Life time costs of surgical versus medical treatment of severe gastroesophageal reflux disease in Finland. Scand J Gastroenterol 1999;32:776-782.
61. Myrvold HE, Lundell L, Liedman B, et al: The cost of omeprazole versus open antireflux surgery in the long-term management of reflux oesophagitis. Gut 2001;49:488-494.
62. Lundell L, Dalenbäck J, Janatuinen E, Hattlebakk J, et al: Comprehensive one year cost analysis of open antireflux surgery in Nordic countries. Br J Surg 1998;85:1002-1005.
63. Inbarcone R, Peters JH, Heimbucher J, et al: A contemporaneous comparison of hospital charges for laparoscopic and open Nissen fundoplication. Surg Endosc 1995;9:151-159.
64. Laycock WS, Oddsdottir M, Franco A, Mansour K: Hunter JG. Laparoscopic Nissen fundoplication is less expensive than open Belsey Mark IV. Surg Endosc 1995;9:426-429.
65. Dire CA, Jones MP, Rulyak SJ, Kahrilas PJ: The economics of laparoscopic Nissen fundoplication. Clin Gastroenterol Hepatol 2003;1:328-332.
66. Rantanen TK, Salo JA, Sipponen JT: Fatal and life-threatening complications in antireflux surgery: Analysis of 5,502 operations. Br J Surg 1999;86:1573-1577.
67. Viljakka M, Luostarinen M, Isolauri J: Complications of open and laparoscopic antireflux surgery: 32-year audit at a teaching hospital. J Am Coll Surg 1997;185:446-450.
68. Watson DI, Baigrie RJ, Jaimeson GG: A learning curve for laparoscopic fundoplication. Definable, avoidable, or a waste of time? Ann Surg 1996;224:198-203.
69. Loustarinen MES, Isolauri JO: Surgical experience improve the long-term results of Nissen fundoplication. Scand J Gastroenterol 1999;34:117-120.
70. Sandbu R, Haglund U, Arvidsson D, Hallgren T: Anti-reflux surgery in Sweden, 1987-1997: A decade of change. Scand J Gastroenterol 2000;35:345-348.
71. Peridikis G, Hinder RA, Lund RJ, Raiser F, Katada N: Laparoscopic Nissen fundoplication: Where do we stand? Surg Laparosc Endosc 1997:7:17-21.
72. Lindeboom MYA, Vu MK, Ringers J, van Rijn PJJ, Neijenhuis P, Masclee AAM: Function of the proximal stomach after partial versus complete laparoscopic fundoplication. Am J Gastroenterol 2003;98:284-290.
73. Lindeboom MA, Ringers J, Straathof JWA, van Rijn PJJ, Neijenhuis P, Masclee AAM: Effect of laparoscopic partial fundoplication on reflux mechanisms. Am J Gastroenterol 2003;98:29-34.
74. Cuschieri A, Hunter J, Wolfe B, Swanstrom LL, Hutson W: Multicenter prospective evaluation of laparoscopic antireflux surgery. Preliminary report. Surg Endosc 1993;7:505-510.
75. Hinder RA, Filipi CJ, Wetscher G, Neary P, DeMeester TR, Perdikis G: Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg 1994;220:472-483.
76. Hunter JG, Swanstrom L, Waring JP: Dysphagia after laparoscopic antireflux surgery. The impact of operative technique. Ann Surg 1996;224:51-57.
77. Hunter JG, Trus TL, Branum GD, Waring JP, Wood WC: A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg 1996;223:673-687.
78. Laine S, Rantala A, Gullichsen R, Ovaska J: Laparoscopic vs. conventional Nissen fundoplication. A prospective randomized study. Surg Endosc 1997;11:441-444.
79. Peters JH, Heimbucher J, Kauer WKH, Incarbone R, Bremner CG, DeMeester TR: Clinical and physiologic comparison of laparoscopic and open Nissen fundoplication. J Am Coll Surg 1995;180:385-393.
80. Pitcher DE, Curet MJ, Martin DT, Castillo RR, Gerstenberger PD, Vogt D, Zucker KA: Successful management of severe gastroesophageal reflux disease with laparoscopic Nissen fundoplication. Am J Surg 1994;168:547-553.
81. Rattner DW, Brooks DC: Patient satisfaction following laparoscopic and open antireflux surgery. Arch Surg 1995;130:289-294.
82. Swanstrom L, Wayne R: Spectrum of gastrointestinal symptoms after laparoscopic fundoplication. Am J Surg 1994;167:538-541.
83. Jansen EH, Horbach JMLM, Klamer M, et al: Plasma pancreatic polypeptide responses to insulin hypoglycemia after Nissen fundoplication. Scand J Gastroenterol 1989;24:9-12.
84. Gooszen HG, Horbach JMLM, Jansen EH, et al: Incidence of vagal nerve damage after antireflux surgery and the relation to symptoms. Gastroenterology 1993;104:A90.
85. Allen R, Rappaport W, Hixson L, Sampliner R, Case T, Fennerty MB: Referral patterns and the results of antireflux operations in patients more than sixty years of age. Surg Gynecol Obstet 1991;173:359-362.
86. Bessell JR, Finch R, Gotley DC, Smithers BM, Nathanson L, Menzies B: Chronic dysphagia following laparoscopic fundoplication. Br J Surg 2000;87:1341-1345.
87. Bessell JR, Adair WD, Smithers BM, Menzies MB, Gotley DC: Early re-operation for acute dysphagia following laparoscopic fundoplication. Br J Surg 2002;89:783-786.
88. Watson DI, Jamieson GG, Devitt PG, Mitchell PC, Game PA: Paraoesophageal hiatus hernia: An important complication of laparoscopic Nissen fundoplication. Br J Surg 1995;82:521-523.
89. Wetscher GJ, Glaser K, Wieschmeyer T, Gadenstaetter M, Prommegger R, Profanter C: Tailored antireflux surgery for gastroesophageal reflux disease: Effectiveness and risk of postoperative dysphagia. World J Surg 1997;21:605-610.
90. Fuchs KH, Heimbucher J, Freys SN, Thide A: Management of gastro-oesophageal reflux disease 1995. Tailored concept of antireflux operations. Dis Esophagus 1994;7:250-254.
91. Kauer WKH, Peters IH, Ireland AP, et al: A tailored approach to antireflux surgery. J Cardiovasc Thorac Surg 1995:109:1-7.
92. Mughal MM, Bancewicz J, Marpies M: Oesophageal manometry and pH recording does not predict the bad results of Nissen fundoplication. Br J Surg 1990;77:43-45.
93. Baigrie RJ, Watson DI, Meyers JC, Jamieson GG: Outcome of laparoscopic Nissen fundoplication in patients with disordered preoperative peristalsis. Gut 1997;40:381-385.
94. Rydberg L, Ruth M, Abrahamsson H, Lundell L: Tailoring of antireflux surgery. A concept subjective to a randomized clinical trial. World J Surg 1999;23:612-618.
95. Banciewicz J, Mughai M, Marples M: The lower oesophageal sphincter after floppy Nissen fundoplication. Br J Surg 1987;74:162.
96. Bjerkestet T, Nordgaard K, Schjonsby H: Effect of Nissen fundoplication operation on the lower esophageal sphincter. Scand J Gastroenterol 1980;15:213.
97. DeMeester TR, Wernly JA, Brian GH, et al: Clinical and in vitro analysis of determinants of gastroesophageal competence. A study of principles of antireflux surgery. Am J Surg 1979;137:39.
98. Rydberg L, Ruth M, Lundell L: Mechanism of action of antireflux procedures. Br J Surg 1999;86;405-410.
99. Lundell L, Abrahamsson H, Ruth M, Sandberg N, Olbe L: Lower esophageal sphincter characteristics and esophageal acid exposure following partial or 360 degrees fundoplication: Results of a prospective, randomized, clinical study. World J Surg 1991;15:115-121.
100. Lundell L, Abrahamsson H, Ruth M, Rydberg L, Lönroth H, Olbe L: Long-term results of a prospective randomized comparison of total fundic wrap (Nissen-Rossetti) or semifundoplication (Toupet) for gastro-oesophageal reflux. Br J Surg 1996;83:830-835.
101. Siewert JR, Isolauri JO, Feussner H: Reoperation following failed fundoplication. World J Surg 1989;13:791-797.
102. Martin CJ, Crookes PF: Reoperation for failed antireflux surgery. Aust NZ J Surg 1990;60:773-778.
103. Luostarinen ME, Isolauri JO, Koskinen MO, Laitinen JO, Matikainen MJ, Lindholm TS: Refundoplication for recurrent gastroesophageal reflux disease. World J Surg 1993;17:587-594.
104. Ellis FJ, Jr, Gibb SP, Heatley GJ: Reoperation after antireflux surgery. Review of 101 cases. Eur J Cardiothorac Surg 1996;10:225-232.
105. Deschamps C, Trastek VF, Allen MS, Pairolero PC, Johnson JO, Larson DR: Long-term results after reoperation for failed antireflux procedure. J Thorac Cardiovasc Surg 1997;113:545-551.
106. Henderson RD, Marryatt G: Recurrent hiatal hernia: Management by thoracoabdominal total fundoplication gastroplasty. Can J Surg 1981;24:151-157.
107. Stein HJ, Feussner H, Siewert JR: Failure of antireflux surgery: Causes and management strategies. Am J Surg 1996;171:36-39.
108. Watson DI Jamieson GG, Game PA, Williams RS, Devitt PG: Laparoscopic re-operation following failed anti-reflux surgery. Br J Surg 1999;86:98-101.
109. Watson DI, Baigrie RJ, Jamieson GG: A learning curve for laparoscopic fundoplication. Definable, avoidable or a waste of time? Ann Surg 1996;224:198-203.
110. Sandbu R, Khamis H, Gustavsson S, Haglund U: Long-term results of antireflux surgery indicate the need for a randomized clinical trial. Br J Surg 2002;89:225-230.
111. Walker SJ, Holt S, Sanderson CJ, Stoddard CJ: Comparison of Nissen total and Lind partial transabdominal fundoplication in the treatment of gastro-oesophageal reflux. Br J Surg 1992:79:410-414.
112. Johnsson F, Holloway RH, Ireland AC, Jamieson GG, Dent J: Effect of fundoplication on transient lower oesophageal sphincter relaxation and gas reflux. Br J Surg 1997;84:686-689.
113. Laws HL, Clements RH, Swillies CM: A randomized, prospective comparison of the Nissen versus the Toupet fundoplication for gastroesophageal reflux disease. Ann Surg 1997;225:647-654.
114. Zornig C, Strate U, Fibbe C, Emmermann A, Layer P: Nissen vs. Toupet laparoscopic fundoplication. Surg Endosc 2002;16:758-766.
115. Watson DI, Jamieson GG, Pike GK, Richardson DN, Devitt PG: A prospective randomized double blind trial between laparoscopic Nissen fundoplication and anterior partial fundoplication. Br J Surg 1999, 86:113-123.
116. Velasco N, Hill LD, Ganna RM, et al: Gastric emptying and gastroesophageal reflux. Am Surg 1982;144:58-62.
117. Maddern GJ, Jamieson GG: Fundoplication enhances gastric emptying. Ann Surg 1985;301:296-299.
118. Vu MK, Straathof JWA, Schaar PJ, et al: Motor and sensory function of the proximal stomach in reflux disease and after laparoscopic Nissen fundoplication. Am J Gastroenterol 1999;94:1481-1489.